Differential (Click to cross reference) amphetamines arsenic ataxia ataxia, cerebellar ataxic gait attention deficit disorder with hyperactivity auditory evoked brainstem potentials autism basal ganglia basal ganglia, lesion of CAT scan, abnormal cerebellar degeneration cerebral cortical atrophy cerebral palsy cranial nerves, toxins effecting dementia developmental abnormality of brain developmental disability drug abuse drug abuse, inhalation drug abuse, neurologic complications of eye movement, disorders of fetus glue sniffing hallucinogens heavy metal intoxication hypokalemic periodic paralysis industrial neurologic disorders insecticides iron, brain lead poisoning LSD marihuana mental retardation methyl benzene MRI MRI, abnormal MRI, hypointense signal foci on neuroophthalmology neuropathology neurotoxin nystagmus nystagmus, pendular nystagmus, rotary occupational neurologic disorders ocular dysmetria ocular flutter opsoclonus optic neuropathy optic neuropathy, toxic P300 poison, mercury poison, neurologic problems with polychlorinated biphenyls prevention of neurologic disorders psychological testing pyramidal tract dysfunction review article seizure solvent status epilepticus thalamus, lesion of thalamus, lesion of-bilateral toxic encephalopathy toxins, nervous system trichloroethylene ventricular enlargement visual acuity, decreased visual evoked response weakness, generalized white matter disease white matter disease, periventricular

Showing articles 50 to 51 of 51 << Previous Methyldopahydrazine as an Adjunct to L-Dopa Therapy in Parkinsonism Neurol 22:384, Chase,T.,et al, 1972 Drug Therapy of Parkinsonism NEJM 287:20, Yahr,M.,et al, 1972 Showing articles 50 to 51 of 51 << Previous